Company Overview of Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc., a clinical stage diabetes therapeutics company, designs and develops insulin-based therapies for the treatment of diabetes in the United States. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals, Inc. was founded in 2004 and is based in Cleveland, Ohio.
10000 Cedar Avenue
Cleveland, OH 44106
Founded in 2004
Key Executives for Diasome Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Angiogenix, Inc.||United States|
|Douglas Industries, Inc.||United States|
|Laniprin Life Sciences, Inc.||United States|
|Adheron Therapeutics, Inc.||United States|
|Abraxis BioScience, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Diasome Pharmaceuticals, Inc., please visit www.diasome.com. Company data is provided by Capital IQ. Please use this form to report any data issues.